APA (7th ed.) Citation

N, A., AS, M., S, A., & AA, A. (2025). CONTACT-02: Limited clinical benefit and a suboptimal control group - Authors' reply. The Lancet. Oncology, 26(10), e512. https://doi.org/10.1016/S1470-2045(25)00538-8

Chicago Style (17th ed.) Citation

N, Agarwal, Merseburger AS, Andrianova S, and Azad AA. "CONTACT-02: Limited Clinical Benefit and a Suboptimal Control Group - Authors' Reply." The Lancet. Oncology 26, no. 10 (2025): e512. https://doi.org/10.1016/S1470-2045(25)00538-8.

MLA (9th ed.) Citation

N, Agarwal, et al. "CONTACT-02: Limited Clinical Benefit and a Suboptimal Control Group - Authors' Reply." The Lancet. Oncology, vol. 26, no. 10, 2025, p. e512, https://doi.org/10.1016/S1470-2045(25)00538-8.